BH
Beth Hecht (See Remarks) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Xeris Biopharma Holdings, Inc. (XERS). The largest single filing was $256K of XERS (25,000 sh × $10.23, as filed), executed Nov 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $16.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
XERS
Xeris Biopharma Holdings, Inc.
XERS · 0 buys · 13 sells
13 filings
Recent filings
XERSSALE
Xeris Biopharma Holdings, Inc.
View filing →
$124K16,667 sh × $7.45
Exec Feb 2
Filed Feb 2 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $124K
16,667 sh × $7.43
Exec Jan 2
Filed Jan 5 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $117K
16,667 sh × $7.01
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $123K
16,667 sh × $7.40
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET XERSSALE Xeris Biopharma Holdings, Inc. View filing → $217K
40,000 sh × $5.43
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET